RECORDATI ORD overview
RECORDATI ORD
> News
PR Newswire published a news.

RECORDATI: TO BE HIGHLIGHTED AT AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY (AACE) ANNUAL MEETING--THE EXPANDED INDICATION FOR ISTURISA® (OSILODROSTAT) FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN ADULT PATIENTS WITH CUSHING'S SYNDROME FOR WHOM SURGERY IS NOT AN OPTION OR HAS NOT BEEN CURATIVE
•
•
PR Newswire •
Stocks •
More RECORDATI ORD news...
Thank you
Chart
RECORDATI ORD
> Analyses
Thank you
Reply
Chart

Londinia
has published a new analysis.
- 0
- 98075
- 16015
- 0
Timeframe : 1H - Simple chart
Status : TARGET REACHED
RECORDATI ORD is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 50.35 EUR. The next resistance
Statistics
- Analyses : 166
- Followers : 2